(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FUCORAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

FUCORAN

ST13

US500000079394803

Class

5

Filing

79394803

Registration

8081506

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

08/04/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

03/12/2024

Registration date

12/30/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/30/2025

Last transaction

08/04/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

01

Owner location

KR

Examiner

DUFFIN, GRACE M

Current location

Historical data usage

Holders and representatives

Holders

JANG, BONG KEUN
JANG, BONG KEUN
JBKLAB Co.,Ltd.
JBKLAB Co., Ltd.

Representatives

James C. Watson TraskBritt

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutraceutical preparations in the nature of dietary supplements containing sea tangle in the form of capsules or powders; nutraceutical preparations in the nature of dietary supplements containing sea tangle extracts; food supplements; nutraceuticals for use as a dietary supplement; nutraceuticals for therapeutic purposes specifically for the treatment of cancerdiabetesviralmetaboliccardiovasculargastrointestinalimmune system related diseases and disorders; nutraceutical preparations in the form of capsules or powders in the nature of nutraceuticals for use as a dietary supplement; nutraceutical preparations in the nature of dietary supplements containing algae in the form of capsules or powders; nutraceutical preparations in the nature of dietary supplements containing fucoidanalginic acidlaminarin in the form of capsules or powders; nutraceutical preparations in the nature of dietary supplements containing fucoidan in the form of capsules or powders; pharmaceutical preparations for the treatment of cancerdiabetesviralmetaboliccardiovasculargastrointestinalimmune system related diseases and disorders for use in the health care industry; dietary supplements; dietary and nutritionally fortified food products adapted for medical purposes in the nature of dietetic foods adapted for medical use; medicated food supplements in the nature of dietetic foods adapted for medical use; pharmaceutical drugs in the nature of pharmaceutical preparations for the treatment of cancerdiabetesviralmetaboliccardiovasculargastrointestinalimmune system related diseases; medicines for the treatment of cancerdiabetesviralmetaboliccardiovasculargastrointestinalimmune system related diseases for human purposes; plant extractsother than essential oilsfor medical and pharmaceutical purposes; nutraceutical preparations for therapeutic or medical purposes specifically for the treatment of cancerdiabetesviralmetaboliccardiovasculargastrointestinalimmune system related diseases and disorders

Publications

History of USPTO decisions and trademark events.

28 publications found

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

08/04/2026

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

07/16/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/13/2026

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

07/06/2026

XXCR

GENERIC MADRID TRANSACTION CREATED

07/06/2026

ES7R

TEAS SECTION 7 REQUEST RECEIVED

04/17/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/30/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/30/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/30/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/11/2025

PUBO

PUBLISHED FOR OPPOSITION

11/11/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/05/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

10/18/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/13/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/02/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/08/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/07/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/07/2025

RFNT

REFUSAL PROCESSED BY IB

09/30/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/04/2024

RFRR

REFUSAL PROCESSED BY MPU

09/04/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/04/2024

CNRT

NON-FINAL ACTION WRITTEN

09/03/2024

DOCK

ASSIGNED TO EXAMINER

08/31/2024

MAFR

APPLICATION FILING RECEIPT MAILED

05/13/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/13/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/02/2024

Continuous trademark protection

Get notified about every new filing that threatens FUCORAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.